Lord’s Mark Industries Ltd – ₹200 Crore Rights Issue & ESOP Approval Post NCLT Scheme

Expert Analysis:

• Lord’s Mark Industries’ fifth Monitoring Committee meeting (3 Jan 2026) approved a rights issue of up to ₹200 crore, to be launched after BSE trading resumes, with promoters allowed to renounce their rights in favour of other investors, signalling intent to broad‑base the shareholder base alongside growth funding.​

• The committee reviewed NCLT‑ordered capital restructuring, including allotment of 42.66 crore shares at a 1.25:1 swap ratio to eligible shareholders of Lord’s Mark Industries Pvt Ltd and extinguishment of ex‑promoter holdings plus up to 5% proportionate reduction in large public holdings, aimed at cleaning up and realigning the capital structure before relisting.​

• A new ESOP pool of at least 2% of equity (on the 42.66 crore share base) was cleared to attract senior talent for the company’s push into renal care and med‑tech (via RenalX acquisition, AI‑based dialysis machines and remote monitoring platform), indicating a pivot toward higher‑tech, higher‑margin healthcare businesses.​